Montara Therapeutics
Montara develops safe and efficacious therapies to improve the lives of patients with neurological diseases.
Montara develops safe and efficacious therapies to improve the lives of patients with neurological diseases.
About the company
Montara Therapeutics is a preclinical-stage biopharmaceutical company pursuing novel approaches to develop safer and more efficacious treatments for neurological diseases. Montara’s BrainOnly platform allows brain-specific pharmacology utilizing existing and novel chemical warheads, restricting deleterious on-target off-tissue peripheral activity. BrainOnly holds the potential to drug numerous targets previously considered undruggable. The company is backed by top-tier investors, including Two Bear Capital, SV Health Investors’ Dementia Discovery Fund, KdT Ventures, and Dolby Family Ventures.
